Aktiia announces $42 million in Series B funding round and rebrands to Hilo
On May 2, Aktiia, a blood pressure intelligence platform, announces an oversubscribed $42 million Series B funding round, co-led by Earlybird Health and Wellington Partners.
Alongside this funding, Aktiia is introducing its new brand identity: Hilo - a rebrand which reflects the company's global ambition to make cuffless, clinically validated blood pressure monitoring universally accessible and effortless.
Raghav Gupta, CEO of Hilo, joined us at FH24 to speak in a plenary panel on the defining traits of successful D2C health solutions and how they drive real consumer engagement and loyalty.
DATE: May 2, 2025 | SOURCE: PRNEWSWIRE
Join us and our global community of health innovators in Berlin on November 11-12, 2025.